Financhill
Sell
14

ATNM Quote, Financials, Valuation and Earnings

Last price:
$1.29
Seasonality move :
-5.49%
Day range:
$1.27 - $1.40
52-week range:
$1.03 - $10.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.23x
Volume:
308.6K
Avg. volume:
989.4K
1-year change:
-85.87%
Market cap:
$40.2M
Revenue:
$81K
EPS (TTM):
-$1.39

Earnings Data

Next earnings date for ATNM
Apr 25
2025
Most recent earnings per share
-$0.21
Beat by $0.18
(Dec 31/2024)
Consensus Estimate
-$0.39
(Dec 31/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ATNM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $8.9M -- -- -$0.36 --
04/25/2025 Q1 -- -- -- -$0.29 --
12/31/2024 Q4 -- -- -$0.21 -$0.39 $0.18
11/14/2024 Q3 -- -- -$0.37 -$0.37 -$0.00
08/05/2024 Q2 -- -- -$0.38 -$0.40 $0.02
04/26/2024 Q1 -- -- -$0.31 -$0.52 $0.21
12/31/2023 Q4 -- $81K -$0.33 -$0.54 $0.21
11/02/2023 Q3 $460K -- -$0.49 -$0.57 $0.08
08/14/2023 Q2 -- -- -$0.58 -$0.49 -$0.09
05/15/2023 Q1 -- -- -$0.43 -$0.43 $0.00
12/31/2022 Q4 $1M -- -$0.43 -$0.34 -$0.09
11/14/2022 Q3 -- $45K -$0.38 -- --
08/12/2022 Q2 -- $45K -$0.33 -- --
05/13/2022 Q1 -- $940K -$0.23 -- --
02/24/2022 Q4 -- $23K -$0.36 -- --
11/12/2021 Q3 -- $233K -$0.30 -- --
07/30/2021 Q2 -- $266K -$0.25 -- --
05/14/2021 Q1 -- $622K -$0.29 -- --
12/31/2020 Q4 -- -- -$0.37 -- --
10/23/2020 Q3 -- -- -$0.36 -- --
06/30/2020 Q2 -- -- -$0.41 -- --
05/08/2020 Q1 -- -- -$0.98 -- --
03/19/2020 Q4 -- -- -$0.80 -- --
10/28/2019 Q3 -- -- -$1.21 -- --
08/09/2019 Q2 -- -- -$1.00 -- --
03/31/2019 Q1 -- -- -$1.50 -- --
03/19/2019 Q4 -- -- -$1.50 -- --
11/09/2018 Q3 -- -- -$1.80 -- --
08/09/2018 Q2 -- -- -$1.20 -- --
03/31/2018 Q1 -- -- -$2.10 -- --
12/31/2017 Q4 -- -- -$1.80 -- --
11/03/2017 Q3 -- -- -$2.70 -- --
08/04/2017 Q2 -- -- -$3.60 -- --
03/31/2017 Q1 -- -- -$4.20 -- --
03/17/2017 Q4 -- -- -$3.60 -- --
10/28/2016 Q3 -- -- -$4.20 -- --
07/29/2016 Q2 -- -- -$4.20 -- --
05/13/2016 Q1 -- -- -$3.00 -- --
04/04/2016 Q4 -- -- -$4.80 -- --
11/27/2015 Q3 -- -- -$3.00 -- --
08/14/2015 Q2 -- -- -$6.00 -- --

Actinium Pharmaceuticals Earnings Questions

  • How Much did Actinium Pharmaceuticals Generate in Revenue Last Quarter?

    Actinium Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Actinium Pharmaceuticals Beat Earnings Last Quarter?

    Actinium Pharmaceuticals announced earnings per share of -$0.21 which represents a beat of analyst forecast a -$0.39 per share.

  • Is Actinium Pharmaceuticals Profitable?

    Actinium Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Actinium Pharmaceuticals EPS Next Year?

    Actinium Pharmaceuticals's earnings are forecast to decrease from -$1.27 per share to -$1.43 per share next year representing a decrease of -3.15%.

  • When is Actinium Pharmaceuticals's Earnings Date?

    Actinium Pharmaceuticals's next earnings date is April 25, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Do I Need to Know About Alcoa Stock?
What Do I Need to Know About Alcoa Stock?

Alcoa (AA) is a global leader in aluminum production. Based…

Is ROOT Stock the Next Big Thing?
Is ROOT Stock the Next Big Thing?

Root Holdings (NASDAQ:ROOT) is the parent company of Root Insurance,…

Is Okta a Good Stock to Buy?
Is Okta a Good Stock to Buy?

Okta (NASDAQ:OKTA) is used by some of the largest firms…

Stock Ideas

Sell
37
Is AAPL Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 31x

Sell
37
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 30x

Sell
31
Is NVDA Stock a Buy?

Market Cap: $2.3T
P/E Ratio: 32x

Alerts

Sell
45
RGC alert for Apr 5

Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.

Sell
25
GDXU alert for Apr 5

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.

Buy
76
SOXS alert for Apr 5

Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock